Paradise Genomics
Northbrook · Founded 2012
About Paradise Genomics
Paradise Genomics is a biotech company providing unparalleled utility in the diagnosis, prognosis, or therapeutic monitoring of any disease. The company discovers the most complete gene expression signatures for earlier, more accurate, and less intrusive detection of human diseases. Their disruptive approach and process provide unparalleled utility in the diagnosis, prognosis, or therapeutic monitoring of any disease. Paradise Genomics provides a technology platform for identifying gene expression signatures intended to bring improvements in diagnostics, drug discovery, and management of the disease. The company's genomic platform offers genomic data for product development, enabling the healthcare industry to discover gene expression signatures in blood and diseased tissues. It was founded in 2012 and is headquartered in Northbrook, Illinois, USA.
Company Facts
- Founded: 2012
- Legal name: Paradise Genomics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $650.0K
- Funding stage: Seed
- Last round: Seed (Jan 2014)
- Website: paradisegenomics.com
- Phone: 224-235-4815
Social Profiles
Canonical: https://fsome.com/organization/paradise-genomics-8286490 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.